Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions

Atherosclerosis

Volumn 145, Issue 2, 1999, Pages 253-260

  Millar, John S ^a   Anber, Vian ^a   Shepherd, James ^a   Packard, Chris J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Gangliosides; Glycolipids; Neuraminidase; Oligosaccharides

Indexed keywords

CHONDROITIN 6 SULFATE; CIPROFIBRATE; LIPOPROTEIN; PROTEOGLYCAN; SIALIC ACID; SIALIDASE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANTILIPEMIC AGENTS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CHOLESTEROL; CLOFIBRIC ACID; CORONARY ARTERIOSCLEROSIS; FEMALE; G(M3) GANGLIOSIDE; GLYCOSPHINGOLIPIDS; HUMANS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; PROTEOCHONDROITIN SULFATES;

EID: 0032773820     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00071-4     Document Type: Article

References (28)

1. La Belle M, Krauss RM. Differences in carbohydrate content of low density lipoprotein subclass patterns. J Lipid Res 1990;31:1577-88.
2. Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP, Guevara J Jr, Gotto Jr AM, Morrisett JD. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 1992;33:805-17.
3. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun 1989;162:206-11.
4. Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content. Atherosclerosis 1985;55:93-105.
5. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988;8:851-7.
6. Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler Thromb Vasc Biol 1997;17:2507-14.
7. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ, editor. Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. NY: Wiley-Interscience, 1972:181-274.
8. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990;83:59-67.
9. Lipid Research Clinics Program Manual of Laboratory Operations. Vol 1, Lipid and Lipoprotein Analysis. National Institutes of Health, Bethesda, MD 20014, DHEW Publications (NIH), 1975; 75-628.
10. Markwell MAK, Hass SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-10.
11. Egusa G, Brady DW, Grundy SM, Howard BV. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res 1983;24:1261-7.
12. Miettinen T, Takki-Lukkainen I-I. Use of butyl acetate in determination of sialic acids. Acta Chem Scand 1959;13:856-8.
13. Habeeb AFSA. Determination of free amino groups in protein by trinitrobenzoic acid. Anal Biochem 1966;14:328-36.
14. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996;124:261-71.
15. Camejo G, Baron M, Lopez F. Structural properties of LDL and LDL subfractions controlling its interactions with arterial proteoglycans. In: Fidge NH, Nestel PJ, editors. Atherosclerosis VII. Amsterdam, The Netherlands: Elsevier Science Publishers B.V. (Biomedical Division), 1986:431-4.
16. Barbosa DS, Maranhão RC, Araújo FB, Chang YI, Hirata MH, Abdalla DSP. Sialic acid and oxidizability of low density lipoprotein subfractions of hyperlipidemic patients. Clin Biochem 1995;28:435-41.
17. Melajärvi N, Gylling H, Miettinen TA. Sialic acids and the metabolism of low density lipoprotein. J Lipid Res 1996;37:1625-31.
18. Orekhov AN, Tertov W, Mukhin DN. Desialylated low density lipoprotein-naturally occurring lipoprotein with atherogenic potency. Atherosclerosis 1991;86:153-61.
19. Ruelland A, Gallou G, Legras B, Paillard F, Cloarec L. LDL sialic acid content in patients with coronary artery disease. Clin Chim Acta 1993;221:127-33.
20. Jaakkola O, Solakivi T, Tertov VV, Orekhov AN, Miettinen TA, Nikkari T. Characteristics of low-density lipoprotein subtractions from patients with coronary artery disease. Coron Artery Dis 1993;4:379-85.
21. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN. Multiple-modified desialated low density lipoproteins that cause intracellular lipid accumulation. Lab Invest 1992;67:665-75.
22. Chappey B, Myara I, Giral P, Kerharo G, Plainfosse MC, Levenson J, Simon A, Moatti N, PCVMETRA Group. Evaluation of sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 1995;15:334-9.
23. Lussier-Cacan S, Bard J-M, Boulet L, Nestruck AC, Grothé A-M, Fruchart J-C, Davignon J. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III. Atherosclerosis 1989;78:167-82.
24. Camejo G, Olofsson S-O, Lopez F, Carlsson P, Bondjers G. Identification of apo B100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis 1988;8:368-77.
25. Rall SC Jr., Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982;257:4171-8.
26. Karathanasis SK, Zannis VI, Breslow JL. Isolation and characterization of cDNA clones corresponding to two different human apo C-III alleles. J Lipid Res 1985;26:451-6.
27. Wynn CH. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP1) with sulphatide, GM1-ganglioside and globotriosylceramide. Biochem J 1986;240:921-4.
28. Mikhailenko IA, Dubrovskaya SA, Korepanova OB, Timofeeva NG, Morozkin AD, Prokazova NV, Bergelson LD. Interaction of low-density lipoproteins with gangliosides. Biochim Biophys Acta 1991;1085:299-305.